Oncology Ventures is a New York venture firm investing in commercially validated startups transforming cancer care, from early detection and navigation to treatment, clinical research and survivorship. Founded by cancer survivor Ben Freeberg, it announced an oversubscribed $62M Fund II in 2026 and has a strategic collaboration with Texas Oncology.